Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Drug Discovery Informatics Market

Drug Discovery Informatics Market Share

Report ID: GMI12667
Published Date: Dec 2024
Report Format: PDF

Download Free Sample

Drug Discovery Informatics Market Share

The competitive landscape in the market is characterized by a mix of global pharmaceutical and biotechnology companies and regional players. Established pharmaceutical giants offer well-known drug discovery informatics software and services. Companies are focusing on product differentiation, regulatory approvals, and strategic partnerships to strengthen their position in this competitive market.

Drug Discovery Informatics Market Companies

Few of the prominent players operating in the drug discovery informatics industry include:

Accenture
Agilent Technologies
Albany Molecular Research
Boehringer Ingelheim International
Charles River Laboratories
Collaborative Drug Discovery
Eurofins Scientific
Illumina
Jubilant Life Sciences
Novo Informatics
Oracle Corporation
Selvita

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The drug discovery informatics industry was valued at USD 3.5 billion in 2024 and is estimated to grow at an 11.5% CAGR from 2025 to 2034, driven by increased R&D investments in oncology, infectious diseases, and personalized medicine.

The software segment recorded USD 2.2 billion in 2024 and is expected to grow further as advanced software solutions are critical for managing large datasets and integrating multi-omics data in complex drug discovery processes.

The U.S. drug discovery informatics market was valued at USD 1.4 billion in 2024, driven by the rising prevalence of chronic disorders and significant investments in personalized medicine, genomics, and biologics.

Key players in the market include Accenture, Agilent Technologies, Albany Molecular Research, Boehringer Ingelheim International, Charles River Laboratories, Collaborative Drug Discovery, Eurofins Scientific, Illumina, Jubilant Life Sciences, Novo Informatics, and Oracle Corporation.